Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,320
datasets available to search
ShareScore release 0.9.0
Dataset results
1,320 results for “cystic fibrosis”
Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients
ClinicalTrials.gov study NCT01746095. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT)
ClinicalTrials.gov study NCT02477319. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa
ClinicalTrials.gov study NCT00712166. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis
ClinicalTrials.gov study NCT00097773. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Phase 2 Study to Evaluate Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis
ClinicalTrials.gov study NCT03911713. IPD Sharing: NO. Countries: 7. Publications: 1.
Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit
ClinicalTrials.gov study NCT04210427. IPD Sharing: NO. Countries: 1. Publications: 7.
A Phase 3 Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-cystic
ClinicalTrials.gov study NCT02392234. IPD Sharing: Not stated. Countries: 11. Publications: 4.
Nasally Delivered Pulmozyme for Sinusitis in Cystic Fibrosis
ClinicalTrials.gov study NCT00416182. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 3 Study of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)
ClinicalTrials.gov study NCT03525444. IPD Sharing: Not stated. Countries: 13. Publications: 2.
A Study of VX-445 in Healthy Subjects and Subjects With Cystic Fibrosis
ClinicalTrials.gov study NCT03227471. IPD Sharing: Not stated. Countries: 4. Publications: 3.
Trikafta in Cystic Fibrosis Patients
ClinicalTrials.gov study NCT03506061. IPD Sharing: NO. Countries: 1. Publications: 1.
28 Day Repeat Dose in Cystic Fibrosis Patients
ClinicalTrials.gov study NCT00903201. IPD Sharing: YES. Countries: 5. Publications: 1.
Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis
ClinicalTrials.gov study NCT01859390. IPD Sharing: NO. Countries: 1. Publications: 4.
A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF)
ClinicalTrials.gov study NCT05033080. IPD Sharing: NO. Countries: 12. Publications: 2.
Absorptive Clearance After Inhaled Osmotics in Cystic Fibrosis
ClinicalTrials.gov study NCT01223183. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del
ClinicalTrials.gov study NCT03601637. IPD Sharing: NO. Countries: 2. Publications: 3.
Safety and Tolerability Study of Allogeneic Mesenchymal Stem Cell Infusion in Adults With Cystic Fibrosis
ClinicalTrials.gov study NCT02866721. IPD Sharing: NO. Countries: 1. Publications: 10.
A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Hav
ClinicalTrials.gov study NCT05076149. IPD Sharing: NO. Countries: 20. Publications: 2.
Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients
ClinicalTrials.gov study NCT02532764. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Roll-Over Study of Ivacaftor in Cystic Fibrosis Pediatric Subjects With a CF Transmembrane Conductance Regulator Gene (CFTR) Gating Mutation
ClinicalTrials.gov study NCT01946412. IPD Sharing: Not stated. Countries: 3. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.